glucagon like peptide 1 receptor agonist

anti obesity medication, cagrilintidesemaglutide, diabetes, eli lilly, Eli Lilly and Company, glucagon like peptide 1, glucagon like peptide 1 receptor agonist, health medical pharma, hospitality recreation, john sharretts, Novo Nordisk, obesity, peptide hormones, semaglutide, Tech Industry, Tech News, tirzepatide, weight loss

FDA Approves a New Obesity Drug Poised to Dethrone Wegovy

November 8, 2023

Ed Cara

There’s officially a new and fierce competitor for Novo Nordisk’s Wegovy (semaglutide) when it comes to weight loss. On Wednesday, the Food and Drug Administration approved the drug tirzepatide, developed by Eli Lilly, as a treatment for obesity. The w…
Read more: FDA Approves a New Obesity Drug Poised to Dethrone Wegovy
anti obesity medication, counterfeit consumer good, diabetes, eli lilly, Eli Lilly and Company, glucagon like peptide 1 receptor agonist, health medical pharma, insulin, medication, obesity, peptide hormones, Pharmaceutical industry, semaglutide, Tech Industry, Tech News, type 2 diabetes

Fake Ozempic Has Sent Several People to the Hospital, Health Agency Warns

October 30, 2023

Ed Cara

Health officials in Austria are the latest to warn the public to stay away from sketchy sources of semaglutide, the active ingredient in popular weight loss drugs Wegovy and Ozempic, following recent reports of severe adverse effects linked to counterf…
Read more: Fake Ozempic Has Sent Several People to the Hospital, Health Agency Warns
anti obesity medication, clinical research, clinical trial, eli lilly, glucagon like peptide 1 receptor agonist, health medical pharma, hospitality recreation, lilly, management of obesity, mounjaro, Novo Nordisk, obesity, peptide hormones, placebo, semaglutide, Tech Industry, Tech News, thomas wadden, tirzepatide, weight loss

Eli Lilly’s Obesity Drug Helped People Lose 25% of Their Weight in Latest Trial

October 16, 2023

Ed Cara

New research suggests that Eli Lilly’s tirzepatide can boost existing efforts to lose weight. The company’s latest clinical trial found that people who dropped at least 5% of their weight before taking the drug went on to lose substantially more weight…
Read more: Eli Lilly’s Obesity Drug Helped People Lose 25% of Their Weight in Latest Trial
anti obesity medication, compounding, eli lilly, eli lilly and, Eli Lilly and Company, glucagon like peptide 1 receptor agonist, health medical pharma, lilly, mounjaro, mounjaro tirzepatide, Novo Nordisk, obesity, peptide hormones, Pharmaceutical industry, pharmacy, semaglutide, Tech Industry, Tech News, tirzepatide, wegovy

Eli Lilly Is on the Warpath, Now Suing Pharmacies and Spas for Selling Compounded Mounjaro

September 21, 2023

Ed Cara

The arms race over the next generation of obesity drugs is continuing to heat up. This week, pharmaceutical company Eli Lilly announced it was suing several pharmacies, spas, and wellness centers in the U.S. for allegedly selling unauthorized copycats …
Read more: Eli Lilly Is on the Warpath, Now Suing Pharmacies and Spas for Selling Compounded Mounjaro
anti obesity medication, diabetes, eli lilly, Eli Lilly and Company, gastroparesis, glucagon like peptide 1, glucagon like peptide 1 receptor agonist, health medical pharma, jaclyn bjorklund, Novo Nordisk, peptide hormones, semaglutide, Tech Industry, Tech News, tirzepatide

Makers of Ozempic and Mounjaro Sued Over Allegedly ‘Downplaying’ Severe Side Effects

August 3, 2023

Ed Cara

The makers of two popular but off-label weight loss drugs are now being sued over complications allegedly linked to their use. This week, a Louisiana woman filed a complaint against the companies Novo Nordisk and Eli Lilly, arguing that they have misle…
Read more: Makers of Ozempic and Mounjaro Sued Over Allegedly ‘Downplaying’ Severe Side Effects
anti obesity medication, Food and Drug Administration, gizmodo, glucagon like peptide 1 receptor agonist, health medical pharma, liraglutide, nova nordisk, Novo Nordisk, obesity, peptide hormones, semaglutide, suicidal ideation, Tech Industry, Tech News

Ozempic Under Investigation Following Reports of Suicidal Thoughts

July 27, 2023

Nikki Main

UK regulators are investigating the Ozempic and Saxenda weight loss drugs over reports that patients experienced suicidal and self-harming thoughts while taking the medications. The drugs skyrocketed in popularity in the U.S. as doctors began prescribi…
Read more: Ozempic Under Investigation Following Reports of Suicidal Thoughts

November 2024
M	T	W	T	F	S	S
	1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30

November 2024

About Us

Welcome to encircle News! We are a cutting-edge technology news company that is dedicated to bringing you the latest and greatest in everything tech. From automobiles to drones, software to hardware, we’ve got you covered.

At encircle News, we believe that technology is more than just a tool, it’s a way of life. And we’re here to help you stay on top of all the latest trends and developments in this ever-evolving field. We know that technology is constantly changing, and that can be overwhelming, but we’re here to make it easy for you to keep up.

We’re a team of tech enthusiasts who are passionate about everything tech and love to share our knowledge with others. We believe that technology should be accessible to everyone, and we’re here to make sure it is. Our mission is to provide you with fun, engaging, and informative content that helps you to understand and embrace the latest technologies.

From the newest cars on the road to the latest drones taking to the skies, we’ve got you covered. We also dive deep into the world of software and hardware, bringing you the latest updates on everything from operating systems to processors.

So whether you’re a tech enthusiast, a business professional, or just someone who wants to stay up-to-date on the latest advancements in technology, encircle News is the place for you. Join us on this exciting journey and be a part of shaping the future.

Podcasts

TWiT 1006: Underwater Alien Civilizations – Bluesky Growth, Tyson Vs. Paul, AI Granny – This Week in Tech (Audio)

How Bluesky, Alternative to X and Facebook, Is Handling Explosive Growth Netflix's Live Mike Tyson Vs. Jake Paul Fight Battling Sound & Streaming Glitches In Lead-Up To Main Event Biden Asked Microsoft to "Raise the Bar on Cybersecurity." He May Have Helped Create an Illegal Monopoly. CFPB looks to place Google under federal supervision, setting up clash Apple's Tim Cook Has Ways to Cope With the Looming Trump Tariffs Apple Removes Another RFE/RL App At Request Of Russian Regulator Here's Why I Decided To Buy 'InfoWars' Elon Musk's X Corp. files notice in Alex Jones' Infowars bankruptcy case Spotify's Plans For AI Generated Music, Podcasts, and Recommendations, According To Its Co-President, CTO, and CPO Gustav Söderström This 'AI Granny' Bores Scammers to Tears Congress ponders underwater alien civilizations, human hybrids, and other unexplained stuff In Memoriam: Thomas E. Kurtz, 1928–2024 Host: Leo Laporte Guests: Alex Kantrowitz, Daniel Rubino, and Iain Thomson Download or subscribe to This Week in Tech at https://twit.tv/shows/this-week-in-tech Get episodes ad-free with Club TWiT at https://twit.tv/clubtwit

Encircle News!

Category: glucagon like peptide 1 receptor agonist

FDA Approves a New Obesity Drug Poised to Dethrone Wegovy

Fake Ozempic Has Sent Several People to the Hospital, Health Agency Warns

Eli Lilly’s Obesity Drug Helped People Lose 25% of Their Weight in Latest Trial

Eli Lilly Is on the Warpath, Now Suing Pharmacies and Spas for Selling Compounded Mounjaro

Makers of Ozempic and Mounjaro Sued Over Allegedly ‘Downplaying’ Severe Side Effects

Ozempic Under Investigation Following Reports of Suicidal Thoughts

Follow Us

Featured Posts

About Us

Podcasts

TWiT 1006: Underwater Alien Civilizations – Bluesky Growth, Tyson Vs. Paul, AI Granny – This Week in Tech (Audio)